Publications

2004

Lechpammer M, Lukac J, Lechpammer S, Kovacević D, Loda M, Kusić Z. Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy. Int J Colorectal Dis. 2004;19(2):114-20.
Berger R, Febbo PG, Majumder PK, Zhao JJ, Mukherjee S, Signoretti S, et al. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res. 2004;64(24):8867-75.
De Cecco L, Marchionni L, Gariboldi M, Reid JF, M Lagonigro S, Caramuta S, et al. Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2. Oncogene. 2004;23(49):8171-83.
Ince TA, Crum CP. Telomerase: promise and challenge. Hum Pathol. 2004;35(4):393-5.

2003

Garcia-Cao I, Lafuente MJ, Criado LM, Diaz-Meco MT, Serrano M, Moscat J. Genetic inactivation of Par4 results in hyperactivation of NF-kappaB and impairment of JNK and p38. EMBO Rep. 2003;4(3):307-12.
Magro CM, Klinger DM, Adams PW, Orosz CG, Pope-Harman AL, W Waldman J, et al. Evidence that humoral allograft rejection in lung transplant patients is not histocompatibility antigen-related. Am J Transplant. 2003;3(10):1264-72.
Allen EA, Parwani AV, Siddiqui MT, Clark DP, Ali SZ. Cytopathologic findings in breast masses in men with HIV infection. Acta Cytol. 2003;47(2):183-7.
Bubman D, Cesarman E. Pathogenesis of Kaposi's sarcoma. Hematol Oncol Clin North Am. 2003;17(3):717-45.
Chadburn A, Narayanan S. Lymphoid malignancies: immunophenotypic analysis. Adv Clin Chem. 2003;37:293-353.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700